A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)

Clinical trial NCT00539968 · TERMINATED

Trial details

NCT number: NCT00539968
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Breast Cancer Ovarian Cancer Lung Cancer Gastric Cancer

Start date: 2007-06-01
Primary completion: 2009-12-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.